CHDArrhythmiasDiabetesLipidologyHeart FailureHypertensionStrokeThrombosis
Log in
Username
Password
Remember me
Bookmark this site|Register Me|Forgotten Password
Welcome to InCirculation.net
InCirculation.net is a professional cardiovascular resource intended for a global audience of specialists, generalists, researchers, and other healthcare professionals 		Would you like to know what else InCirculation.net has to offer? Take the tour of InCirculation.net
Click here to register

Congress Reports

 print this page   back


Page summary
Text size
Congress reports quick search
The latest news from International Congresses
 

Drug-related information may refer to unlicensed products or uses that may not be approved in your country. Please consult your local prescribing information for advice.

European Society of Cardiology 2008


InCirculation.net Congress Reports and News covered all of the major trials presented during the 2008 congress of the European Society of Cardiology in Munich, Germany.


Congress News

4 September 2008

ONTARGET analysis: BP lowering has limited benefits, may cause harm in high-risk patients

3 September 2008

Apixaban shows 'promising' ischemic event reduction but ups bleeds

2 September 2008

DES-PCI 'inferior' to CABG for left-main, three-vessel CAD

SEAS disappointing, but ezetimibe cancer risk refuted

1 September 2008

GISSI-HF: No benefit from statin therapy in heart failure

PCI ‘reasonable’ in diabetic patients with multivessel disease

BEAUTIFUL: lowering heart rate fails to reduce CV events overall

31 August 2008

PUFA provide modest benefit in HF



Congress Reports

Day 2, 31 August 2008

 Percutaneous coronary intervention: ‘First-in-man’ use of bevacizumab-eluting stent, intravascular ultrasound use ‘should be routine’

 Adjunctive treatment in acute coronary syndromes

 Prasugrel ‘attractive alternative’ to clopidogrel, give glycoprotein IIa/IIIb inhibitors ‘in ambulance’

 More data support thrombectomy over conventional PCI: 12-month follow-up data from CARESS-in-AMI presented

 The new ‘universal’ definition of myocardial infarction

 Telmisartan in high-risk patients without heart failure – The TRANSCEND study

Day 3, 1 September 2008

 Predicting and preventing atrial fibrillation

 Hot Line II: LEADERS study shows that novel biolimus stent is ‘non-inferior’ to sirolimus stent

 Heart failure: ‘Less malignant than cancer,’ but prognosis for patients remains poor

 Hot Line II: DECREASE III highlights further statin benefits

Day 4, 2 September 2008

 EUROPA re-analysis shows that resting heart rate predicts mortality, and ‘synergy’ of perindopril and calcium channel blockers

 Fit to play? Cardiac abnormalities in sports

 Hotline III: The REGENT and IBIS-2 trials

 Hotline III: The 3T/2R and FIRE trials

 BACH study findings ‘very much in vogue’; EVEREST data used to assess post-discharge prognosis in acute heart failure

 EUROTRANSFER: “Real-world” insight into STEMI management

Day 5, 3 September 2008

 Depression in heart disease: Recognising and treating the problem

 Clinical Trials Update III: The Euro Consumer Heart Index 2008 and EUROASPIRE III

Day 3, 1 September 2008

 Perspectives in heart failure treatment

Day 5, 3 September 2008

 Clinical Trials Update III: The ATHENA and REVERSE trials

 Section feedback  Send to a friend 
 Top of page
All rights reserved. This website is intended for an international audience. Privacy PolicyLegal NoticeTerms and Conditions